What are the legal challenges and prevalence of adverse reactions from COVID-19 vaccines based on clinical trial data?

Brianne Dressen explains that vaccine injury cases face unique legal obstacles due to the PREP Act, which provides robust protections for vaccination programs. Unlike typical injury cases that would be "open and shut," vaccine-related lawsuits encounter impenetrable legal barriers because vaccines are held to different standards in the United States. Regarding prevalence, Dressen cites two key studies showing significant adverse event rates. Freeman and Doshi's analysis of clinical trial data found serious adverse events occur at a rate of 1 in 800 participants. Additionally, the German government has officially recognized "post vaccine syndrome" as a severe multi-system condition occurring after COVID vaccination, with rates similar to long COVID at 2 in 5,000 cases. These findings highlight the gap between reported adverse events and actual clinical trial data, raising questions about transparency in vaccine safety reporting.